Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Neovascularization, Age-related Macular Degeneration”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Testing effectiveness (Phase 2)Study completedNCT00043680
What this trial is testing

Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 60
Testing effectiveness (Phase 2)Study completedNCT02484690
What this trial is testing

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal Neovascularization
Hoffmann-La Roche 273
Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16
Post-approval studies (Phase 4)Study completedNCT03117634
What this trial is testing

An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Who this might be right for
Age Related Macular DegenerationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 54
Large-scale testing (Phase 3)Ended earlyNCT01402544
What this trial is testing

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Who this might be right for
Age-Related Macular Degeneration
University of California, San Diego 20
Large-scale testing (Phase 3)Study completedNCT00331864
What this trial is testing

SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Novartis 531
Testing effectiveness (Phase 2)UnknownNCT00809419
What this trial is testing

The NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

Who this might be right for
Age Related Macular Degeneration
NeoVista 32
Not applicableLooking for participantsNCT07255859
What this trial is testing

AVIGA3 (Cohort 2.0)

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Post-approval studies (Phase 4)Study completedNCT00135837
What this trial is testing

Photodynamic Therapy in Occult-Only Lesions (POOL)

Who this might be right for
Age-Related Macular Degeneration
Novartis 202
Early research (Phase 1)Study completedNCT00018070
What this trial is testing

Identification and Treatment of Feeder Vessels in Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00001615
What this trial is testing

Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
National Eye Institute (NEI) 180
Testing effectiveness (Phase 2)UnknownNCT00100087
What this trial is testing

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Theragenics Corporation 30
Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Post-approval studies (Phase 4)Study completedNCT01148511
What this trial is testing

Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 99
Testing effectiveness (Phase 2)Study completedNCT00413829
What this trial is testing

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Who this might be right for
Age Related Macular Degeneration
Insel Gruppe AG, University Hospital Bern 20
Large-scale testing (Phase 3)Study completedNCT00051129
What this trial is testing

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationMaculopathy, Age-RelatedAge-Related Maculopathies+2 more
Alcon Research 291
Next Page